← Back
Data updated: Mar 10, 2026
MARSAM PHARMS LLC
DermatologyCardiovascular
MARSAM PHARMS LLC is a generic drug manufacturer focused on Dermatology, Cardiovascular. Key products include FAMOTIDINE.
1987
Since
13
Drugs
-
Trials
149
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
CHLORPROMAZINE HYDROCHLORIDE 2026-01-26
FUROSEMIDE 2026-01-08
HALOPERIDOL 2025-12-18
VERAPAMIL HYDROCHLORIDE 2025-11-24
DIAZEPAM 2025-11-14
VERAPAMIL HYDROCHLORIDE 2025-11-13
CHLORPROMAZINE HYDROCHLORIDE 2025-10-10
VERAPAMIL HYDROCHLORIDE 2025-09-19
Labeling
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Dermatology 50%
1 drugs
Cardiovascular 50%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (8)
Company Info
- First Approval
- 1987-10-13
- Latest
- 1998-02-23
- Applications
- 19